Considering that adiponectin has been recognized as a significant insulin sensitizer it would be consistent to anticipate that circulating adiponectin levels would be considerable in the presence of an insulin resistant state such as obesity. Here, ADIPOQ is linked to obesity due to melanocortin 4 receptor deficiency.